# FDA 483 - Novo Nordisk A/S - March 25, 2024

Source: https://www.globalkeysolutions.net/records/483/novo-nordisk-as/da5518cf-dd42-4d5b-b2f7-bdbb6dd3182c

> FDA 483 for Novo Nordisk A/S on March 25, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Novo Nordisk A/S
- Inspection Date: 2024-03-25
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [EIR - 2024-03-25](https://www.globalkeysolutions.net/records/eir/novo-nordisk-as/e5940682-7d77-485a-a366-11b1f33ca5dc)
- [MEMO - 2024-03-25](https://www.globalkeysolutions.net/records/memo/novo-nordisk-as/c64eef41-5e75-4ec1-8077-7d00df21947b)

## Related Officers

- [Ralph M. Bernstein](https://www.globalkeysolutions.net/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- [Maxwell Korang-Yeboah](https://www.globalkeysolutions.net/people/maxwell-korang-yeboah/7fa70d10-c535-4754-aae2-9889bee6edf8)
- [Zachary Kraus](https://www.globalkeysolutions.net/people/zachary-kraus/9a85297e-4a21-49a6-a848-bc4a1e759f1a)
- [Lindsey Brown](https://www.globalkeysolutions.net/people/lindsey-brown/ff47f714-146f-474e-a6b8-2cf14c67dd4f)

Company: https://www.globalkeysolutions.net/companies/novo-nordisk-as/b48359f1-0bb7-4fff-80dd-688aab40951b

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c